| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABIOMED INC | 2,150,000 | 194,102,000 | 35.50% | ||
| 2 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 156,864,000 | 28.69% | ||
| 3 | CORIUM INTERNATIONAL INC | 9,353,304 | 75,949,000 | 13.89% | ||
| 4 | ENTELLUS MEDICAL INC | 3,813,197 | 64,291,000 | 11.76% | ||
| 5 | AXOGEN INC | 4,861,111 | 24,306,000 | 4.44% | ||
| 6 | ENDOLOGIX INC | 1,257,468 | 18,480,000 | 3.38% | ||
| 7 | ACURA PHARMACEUTICALS INC | 1,956,397 | 4,891,000 | 0.89% | ||
| 8 | MEDICINOVA INC COM NEW | 1,170,370 | 4,155,000 | 0.76% | ||
| 9 | Catalyst Biosciences | 1,179,352 | 3,779,000 | 0.69% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002537, filed 2016.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
